P913: LOW-DOSE BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH NIROGACESTAT VS BELAMAF MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1/2 DREAMM-5 PLATFORM SUB-STUDY 3

التفاصيل البيبلوغرافية
العنوان:	P913: LOW-DOSE BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH NIROGACESTAT VS BELAMAF MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1/2 DREAMM-5 PLATFORM SUB-STUDY 3
المؤلفون:	Natalie Callander, Paul Richardson, Marek Hus, Vincent Ribrag, Joaquín Martinez-Lopez, Kihyun Kim, Jae Hoon Lee, Meletios A. Dimopoulos, Fredrik Schjesvold, Thierry Facon, Jae-Cheol Jo, Chang-Ki Min, Michał Mielnik, Shinta Cheng, Mary Smith, Caroline J. Breitbach, Chris Brawley, Harjeet Sembhi, John Lamacchia, Sebastian Grosicki
المصدر:	HemaSphere, Vol 7, p e9722122 (2023)
بيانات النشر:	Wiley, 2023.
سنة النشر:	2023
المجموعة:	LCC:Diseases of the blood and blood-forming organs
مصطلحات موضوعية:	Diseases of the blood and blood-forming organs, RC633-647.5
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	2572-9241
Relation:	http://journals.lww.com/10.1097/01.HS9.0000970556.97221.22; https://doaj.org/toc/2572-9241
DOI:	10.1097/01.HS9.0000970556.97221.22
URL الوصول:	https://doaj.org/article/4fa2e377c900412299470016a81646fb
رقم الأكسشن:	edsdoj.4fa2e377c900412299470016a81646fb
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	25729241
DOI:	10.1097/01.HS9.0000970556.97221.22